Singapore markets closed
Straits Times Index
3,314.05 +0.57 (+0.02%) S&P 500
5,320.73 +17.46 (+0.33%) Dow
40,046.94 +43.35 (+0.11%) Nasdaq
16,777.88 +91.91 (+0.55%) Bitcoin USD
67,179.66 +293.02 (+0.44%) CMC Crypto 200
1,364.89 +10.47 (+0.77%)
Soleno Therapeutics, Inc. (SLNO)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 11:22AM EDT. Market open.
| Previous close | 46.16 |
| Open | 45.91 |
| Bid | 46.85 x 100 |
| Ask | 59.28 x 200 |
| Day's range | 45.63 - 47.38 |
| 52-week range | 3.69 - 53.82 |
| Volume | |
| Avg. volume | 422,395 |
| Market cap | 1.735B |
| Beta (5Y monthly) | -1.50 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
While institutions invested in Soleno Therapeutics, Inc. (NASDAQ:SLNO) benefited from last week's 4.8% gain, private equity firms stood to gain the most
Key Insights Significant control over Soleno Therapeutics by private equity firms implies that the general public has...
- GuruFocus.com
CEO Bhatnagar Anish Sells 18,980 Shares of Soleno Therapeutics Inc (SLNO)
Soleno Therapeutics Inc (NASDAQ:SLNO), a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.
- GuruFocus.com
Insider Sell: CFO James Mackaness Sells 5,175 Shares of Soleno Therapeutics Inc (SLNO)
Soleno Therapeutics Inc (NASDAQ:SLNO), a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.
© 2024 Yahoo. All rights reserved.